Sarepta Therapeutics



Ebitda Endring Dato
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 222.66M 97.54M 2025-03
Insmed USD -241795000 46.45M 2024-12
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Tectonic Therapeutic USD -13483000 5.73M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Sarepta Therapeutics - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.